Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

1334378-48-1

Sulfadimethoxine-(phenyl-13C6)

1334378-48-1
51022-70-9

Salbutamol sulfate

51022-70-9
737-31-5

Sodium amidotrizoate EP

737-31-5
121268-17-5

Sodium alendronate 3H2O EP

121268-17-5
57-50-1

Sucrose EP

57-50-1
68-35-9

Sulfadiazine EP

68-35-9
1246820-85-8

Sotalol HCl D6

1246820-85-8
NA

Sildenafil impurity A EP

NA
1398065-65-0

Sotalol D7 HCl

1398065-65-0
69388-84-7

Sulbactam Sodium Salt

69388-84-7
557795-19-4

Sunitinib

557795-19-4
10102-18-8

Sodium selenite anhydrous

10102-18-8
139-05-9

Sodium Cyclamate USP

139-05-9
284461-73-0

Sorafenib

284461-73-0
51-34-3

Scopolamine

51-34-3
72522-40-8

Serricornine

72522-40-8
1392129-96-2

Sulfaclozine sodium monohydrate

1392129-96-2
118-61-6

Ethyl Salicylate

118-61-6
654671-77-9

Sitagliptin Phosphate monohydrate

654671-77-9
186521-88-0

(N,N-didemethyl) 1-Hydroxy Sibutramine Hydrocholride

186521-88-0